Innovative Therapy

KOLOA, Hawaii — With its new microscope, Haag-Streit aims to improve ergonomics and workflow in the operating room for ophthalmic surgeons.

VisiRose, a collaboration between Provectus Biopharmaceuticals and Bascom Palmer Eye Institute, is introducing a therapy for the treatment of infectious keratitis and other eye infections, according to a press release.

EyePoint Pharmaceuticals announced that the first patient has been dosed in the global, phase 3 LUGANO clinical trial of Duravyu, formerly EYP-1901, as a treatment for wet age-related macular degeneration, according to a press release.

“The historic underfunding of the ESRD payment system has created disincentives for the development of new drugs, biologicals, devices and innovative treatment options ... ”

CHICAGO — Healio once again welcomed the excitement of the Disruptive Innovator Awards, working with new partners and celebrating nine distinct areas of progress in oncology and hematology.

The European Commission has granted conditional marketing authorization to Filspari, Travere Therapeutics and CSL Vifor announced in a press release.

Fresenius Medical Care has received FDA 510(k) clearance for its 5008X Hemodialysis System, allowing for the start of U.S.-based clinical trials, according to a press release.

ORLANDO — In Health care, and epilepsy care specifically, greater preparation communication and innovation are required to maintain a standard of care when the next major crisis after the COVID-19 pandemic arises, according to a presenter.

EyeBio closed an extension to its Series A financing, ending with $130 million raised, according to a press release.

In the pursuit of progress in patient-centered kidney care, it is essential to recognize the vital role that access to innovation plays in providing hope to people battling kidney disease.